Replies to post #18898 on Radient Pharmaceuticals Corporation fka RXPC

[jimtash]

11.5 If either party terminates the Agreement or the Agreement expires due to non-payment or otherwise, any and all license rights will revert to RXPC. Three months after the date of reversion, RXPC will be entitled to enter new contractual agreements with third parties with regard to such rights.